These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1391266)

  • 1. Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth.
    Walti H; Boulé M; Moriette G; Relier JP
    Biol Neonate; 1992; 61 Suppl 1():48-53. PubMed ID: 1391266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung mechanics (FRC and static pressure-volume diagram) after endotracheal surfactant instillation: preliminary observations.
    Svenningsen NW; Björklund L; Vilstrup C; Werner O
    Biol Neonate; 1992; 61 Suppl 1():44-7. PubMed ID: 1391265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.
    Baraldi E; Pettenazzo A; Filippone M; Magagnin GP; Saia OS; Zacchello F
    Pediatr Pulmonol; 1993 Mar; 15(3):157-62. PubMed ID: 8327278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary effects after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Farstad T; Bratlid D
    Biol Neonate; 1995; 68(4):246-53. PubMed ID: 8580215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
    van Zyl JM; Smith J
    Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment.
    de Winter JP; Merth IT; van Bel F; Egberts J; Brand R; Quanjer PH
    Pediatr Res; 1994 May; 35(5):541-9. PubMed ID: 8065835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional residual capacity and passive compliance measurements after antenatal steroid therapy in preterm infants.
    McEvoy C; Bowling S; Williamson K; Stewart M; Durand M
    Pediatr Pulmonol; 2001 Jun; 31(6):425-30. PubMed ID: 11389574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant increases the uniformity of lung aeration at birth in ventilated preterm rabbits.
    Siew ML; Te Pas AB; Wallace MJ; Kitchen MJ; Islam MS; Lewis RA; Fouras A; Morley CJ; Davis PG; Yagi N; Uesugi K; Hooper SB
    Pediatr Res; 2011 Jul; 70(1):50-5. PubMed ID: 21451432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary functional residual capacity and lung mechanics in surfactant-treated infants.
    Svenningsen NW
    Semin Perinatol; 1992 Jun; 16(3):181-5. PubMed ID: 1514109
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
    McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M
    Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.
    Vilstrup C; Gommers D; Bos JA; Lachmann B; Werner O; Larsson A
    Pediatr Res; 1992 Nov; 32(5):595-9. PubMed ID: 1480463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study.
    Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E
    Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the immediate response to surfactant.
    Kuint J; Reichman B; Neumann L; Shinwell ES
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial.
    Attar MA; Becker MA; Dechert RE; Donn SM
    J Perinatol; 2004 Oct; 24(10):626-30. PubMed ID: 15201857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G
    Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.